Return to Course LibraryCE InformationPrint Course MaterialsBibliographyRegister Now

Release Date
June 28, 2019

 

Expiration Date
June 28, 2021

 


Kevin S. Hughes, MD, FACS
Co-Director, Avon Breast Evaluation Program
Massachusetts General Hospital
Professor of Surgery
Harvard Medical School

 

 

 

 

 

 

5110-101-Level-1-Surgery_Banner.jpg
Format: Archived Webinar
Credit: 1.0 AMA PRA Category 1
  1.0 ANCC Contact hour
  No ARRT credit is available
Tuition:  FREE


Course Overview
When breast cancer patients prepare to undergo lumpectomy for tumor excision, consideration of the aesthetic appearance of the breast post-surgery is essential. Oncoplastic breast surgery represents the integration of plastic surgery techniques into breast cancer surgery in order to preserve an aesthetic outcome and quality of life for the patient while completely removing cancerous tissue.[1] The primary advantage of oncoplastic resection is the significantly lower positive margin rate and improved aesthetic outcome compared to the standard partial mastectomy.[2,3] Oncoplastic breast surgery can also be a more cost-effective option.[2]

Dr. Hughes will discuss Level 1 oncoplastic surgery (OPS) which is performed when less than 20% of breast volume is excised[4]. Included in this presentation will be a review of the history of oncoplastic breast surgery; current surgical techniques; and the use of implantable devices in preparation for lumpectomy, surgical biopsy, or radiation therapy.

1. Macmillan RD, McCulley SJ. Oncoplastic Breast Surgery: What, When and for Whom? Curr Breast Cancer Rep. 2016;8:112-117.
2. Chatterjee A, Dayicioglu D, Khakpour N, Czerniecki BJ. Oncoplastic Surgery: Keeping It Simple With 5 Essential Volume Displacement Techniques for Breast Conservation in a Patient With Moderate- to Large-Sized Breasts. Cancer Control. 2017;24(4):1073274817729043.
3. Bertozzi N, Pesce M, Santi PL, Raposio E. Oncoplastic breast surgery: comprehensive review.  Eur Rev Med Pharmacol Sci. 2017;21(11):2572-2585.
4. Massey EJD, Gouveia PF, Nos C, Poulet B, Sarfati I, Clough KB. A new level 1 oncoplastic technique for breast conserving surgery: rotation glandular flap. Breast. 2013;22(2):186-189.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Discuss the evolution of oncoplastic breast surgery and its advantages compared to traditional partial mastectomy
  • Describe various surgical techniques used in oncoplastic breast surgery
  • Explain how the use of implantable devices assists the surgeon or radiation oncologist in tumor/excision site localization

Faculty
Kevin S. Hughes, MD, FACS

Co-Director, Avon Breast Evaluation Program
Massachusetts General Hospital
Professor of Surgery
Harvard Medical School

After completing medical school at Dartmouth Medical School, Dr. Hughes trained in General Surgery at Mercy Hospital of Pittsburgh, followed by a fellowship in Surgical Oncology at the National Cancer Institute.

Since that time, Dr. Hughes has been actively involved in the diagnosis and treatment of breast cancer. He is well-known for his research in finding the least amount of treatment necessary to obtain the best results, running a national trial on breast cancer in older women. The results have made it now a standard practice to avoid radiation in most older women with early breast cancer. Dr. Hughes is now participating in a trial to extend these results to younger women with less aggressive disease. Dr. Hughes attempts to minimize the treatment needed in all aspects of breast cancer, using sentinel node biopsy, lumpectomy with oncoplastic techniques, genomic studies of tumors and nipple-sparing mastectomy and other minimally invasive techniques, and avoiding, where possible, radiation, axillary dissection, or chemotherapy.

Dr. Hughes is part of a team of specialists – surgeons, breast imagers, and pathologists - dedicated to the management of women (and some men) with breast problems. These dedicated faculty and staff work closely to rapidly screen, diagnose, and manage women who have breast lumps, abnormal mammograms, nipple discharge, breast cancer, and other breast problems, with the goal of providing the best possible treatment with the least amount of trauma and intervention.  

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education to the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials.

For more information go to https://www.uems.eu/areas-of-expertise/cme-cpd/eaccme/mutual-recognition-with-the-united-states

Nurse Continuing Medical Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Radiologic Technologists
~this course does not offer ARRT credit  ~

How to Enroll and Participate
There are no fees or prerequisites to participate in this program. Estimated time to complete this activity is one hour.
Click ENROLL NOW, CONTINUE, CONFIRM ORDER, and ACCESS COURSE NOW.

  • Click on the blue link. Complete the precourse questions and SUBMIT.
  • Click on the blue link again to view the recording.

How to Receive Credit

  • Log-in to your account at www.icpme.us
  • View the entire educational activity session. At the conclusion of the lecture, close the Vimeo window.
  • Return to the course in your account at www.icpme.us.
  • From the COURSE HOME page, click the button for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at www.icpme.us

Your certificate of credit will remain in your account at www.icpme.us as a permanent record of your participation.

 Disclosure Information
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Kevin S. Hughes, MD, has received fees for non-CME/CE services provided to Focal Therapeutics; Hologic, Inc.; and 23andMe. He also has ownership interest greater than 5% in Hughes Risk Apps, LLC.

ICPME and PIM planners and managers have no disclosures.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions?
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10

 

               Jointly provided by
               
 

This activity is supported by an independent educational grant from Hologic, Inc.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.